Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...
Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback